These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29113172)

  • 41. Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.
    Ma X; Wang J; Zhao M; Huang H; Wu J
    Oncol Lett; 2019 Jul; 18(1):465-471. PubMed ID: 31289518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.
    Murphy NC; Biankin AV; Millar EK; McNeil CM; O'Toole SA; Segara D; Crea P; Olayioye MA; Lee CS; Fox SB; Morey AL; Christie M; Musgrove EA; Daly RJ; Lindeman GJ; Henshall SM; Visvader JE; Sutherland RL
    Int J Cancer; 2010 Mar; 126(6):1445-53. PubMed ID: 19676041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
    Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
    J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
    Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Breast; 2015 Oct; 24(5):667-72. PubMed ID: 26346586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
    Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
    Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.
    Zhou D; Ren K; Wang J; Ren H; Yang W; Wang W; Li Q; Liu X; Tang F
    Oncol Lett; 2018 Apr; 15(4):5257-5263. PubMed ID: 29552165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients.
    Huszno J; Kolosza Z
    Oncol Lett; 2019 Dec; 18(6):6275-6283. PubMed ID: 31788105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
    Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
    J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.
    Zati Zehni A; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma‑not otherwise specified.
    Wang J; Song L; Yang S; Zhang W; Lu P; Li S; Li H; Wang L
    Mol Med Rep; 2017 Oct; 16(4):4634-4642. PubMed ID: 28765906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of chemotactic factor receptor 5 gene with breast cancer.
    Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
    Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
    Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TMPRSS3 is a novel poor prognostic factor for breast cancer.
    Rui X; Li Y; Jin F; Li F
    Int J Clin Exp Pathol; 2015; 8(5):5435-42. PubMed ID: 26191247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
    Yang Y; Qian J; Xiang Y; Chen Y; Qu J
    Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
    Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
    Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.
    Kolben T; Harbeck N; Wuerstlein R; Schubert-Fritschle G; Bauerfeind I; Schrodi S; Engel J
    Breast; 2015 Feb; 24(1):24-31. PubMed ID: 25543874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.